A detailed history of Gts Securities LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Gts Securities LLC holds 32,405 shares of AMRN stock, worth $15,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,405
Previous 13,300 143.65%
Holding current value
$15,230
Previous $9,000 122.22%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.57 - $0.8 $11,797 - $16,558
-20,698 Reduced 38.98%
32,405 $20,000
Q2 2024

Aug 14, 2024

BUY
$0.63 - $1.07 $3,486 - $5,921
5,534 Added 11.63%
53,103 $36,000
Q1 2024

May 15, 2024

BUY
$0.82 - $1.35 $2,523 - $4,153
3,077 Added 6.92%
47,569 $42,000
Q4 2023

Feb 14, 2024

BUY
$0.66 - $0.91 $374 - $515
567 Added 1.29%
44,492 $38,000
Q3 2023

Nov 15, 2023

BUY
$0.85 - $1.43 $12,026 - $20,233
14,149 Added 47.52%
43,925 $40,000
Q2 2023

Aug 15, 2023

BUY
$1.12 - $1.49 $33,349 - $44,366
29,776 New
29,776 $35.4 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $190M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.